Medicine
Dermatologic Manifestations of Systemic Lupus Erythematosus
Quick fact
The classic malar rash (butterfly rash) is actually a form of acute cutaneous lupus, and it spares the nasolabial folds—a subtle yet crucial detail for diagnosis.
Why this is interesting
You've probably heard of the 'butterfly rash' of lupus—but did you know that skin symptoms appear in up to 80% of people with SLE and often precede the systemic diagnosis?
Read the full explanation
Understanding Dermatologic Manifestations of Systemic Lupus Erythematosus
Imagine your immune system as a security team that normally attacks viruses and bacteria. In systemic lupus erythematosus (SLE), this team gets confused and starts attacking your own body, including your skin. The skin becomes a visible battlefield where immune complexes—clumps of antibodies and antigens—deposit in the tissue, triggering inflammation and damage. Because the skin is exposed, it often shows the first signs of this internal conflict. The manifestations are broadly grouped by how they look and how long they last. The classic 'butterfly rash' across the cheeks and nose is an acute form, often appearing during flares. Discoid lupus produces round, scaly patches that can scar and cause permanent hair loss. Subacute cutaneous lupus produces psoriasis-like or ring-shaped rashes, usually on sun-exposed areas. Understanding these patterns is key because they not only help diagnose SLE but also give clues about disease severity and involvement of other organs.
A deeper explanation
The mechanisms behind these skin lesions are rooted in autoimmunity and photosensitivity. Ultraviolet (UV) light from the sun triggers keratinocyte apoptosis, exposing nuclear antigens. In SLE, the immune system fails to clear these apoptotic cells properly, leading to the formation of autoantibodies against nuclear components (like ANA, anti-Ro/SSA). When these antibodies bind to their targets, immune complexes deposit in the dermal-epidermal junction, activating complement and attracting inflammatory cells, which cause tissue damage. The type and depth of inflammation determine the clinical appearance: acute lesions show interface dermatitis with vacuolar changes, subacute lesions feature epidermal keratinocyte damage, and chronic discoid lesions show marked follicular plugging and scarring. This understanding explains why photosensitivity is a hallmark and why sun protection is crucial. Recognition of these manifestations is clinically vital: the malar rash is a major criterion in classification systems, and discoid lesions confer an increased risk of scarring alopecia. By linking skin findings to the underlying immune processes, clinicians can diagnose SLE earlier, monitor disease activity, and tailor treatment, including topical steroids, antimalarials, and systemic immunosuppressants for refractory cases.